A review of radiopharmaceuticals over the past decade: Over the hills and through the woods
Journal Article
·
· Journal of Nuclear Medicine Technology; (United States)
OSTI ID:5450308
- Bowman Gray School of Medicine, Winston-Salem, NC (USA)
- Massachusetts General Hospital, Boston (USA)
This special anniversary review article summarizes significant advances and developments that have occurred in the field of radiopharmaceuticals and nuclear medicine. Advances in technetium-99m chemistry include the development of hepatobiliary radiopharmaceuticals, technetium-99m myocardial perfusion agents and renal imaging. In addition, advances made with radiolabeled antibodies and proteins, therapeutic radiopharmaceuticals, and positron emission tomography are discussed. The authors conclude that radiopharmaceutical development has progressed from a random walk through shelves of reagents to an organized plan of drug design, based upon demonstrated structural-activity relationships.
- OSTI ID:
- 5450308
- Journal Information:
- Journal of Nuclear Medicine Technology; (United States), Journal Name: Journal of Nuclear Medicine Technology; (United States) Vol. 18:2; ISSN JNMTB; ISSN 0091-4916
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radiopharmaceuticals for cardiac imaging
Radiopharmaceuticals: Progress and clinical perspectives. Volume I
Harvard-MIT Research Program in short-lived radiopharmaceuticals: Technical progress report for the period March 15, 1986--August 1, 1988
Journal Article
·
Sat Nov 30 23:00:00 EST 1985
· Radiol. Clin. North Am.; (United States)
·
OSTI ID:5808398
Radiopharmaceuticals: Progress and clinical perspectives. Volume I
Book
·
Tue Dec 31 23:00:00 EST 1985
·
OSTI ID:5902195
Harvard-MIT Research Program in short-lived radiopharmaceuticals: Technical progress report for the period March 15, 1986--August 1, 1988
Technical Report
·
Thu Sep 01 00:00:00 EDT 1988
·
OSTI ID:6941610
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIBODIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BILIARY TRACT
BODY
CARDIOVASCULAR SYSTEM
CHEMICAL PROPERTIES
COMPUTERIZED TOMOGRAPHY
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DIAGNOSTIC USES
DIGESTIVE SYSTEM
DRUGS
EMISSION COMPUTED TOMOGRAPHY
GLANDS
HEART
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINE 131
IODINE ISOTOPES
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
KIDNEYS
LABELLED COMPOUNDS
LIVER
MUSCLES
MYOCARDIUM
NUCLEI
ODD-EVEN NUCLEI
ORGANS
POSITRON COMPUTED TOMOGRAPHY
RADIOISOTOPES
RADIOPHARMACEUTICALS
TECHNETIUM 99
TECHNETIUM ISOTOPES
TOMOGRAPHY
USES
YEARS LIVING RADIOI
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIBODIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BILIARY TRACT
BODY
CARDIOVASCULAR SYSTEM
CHEMICAL PROPERTIES
COMPUTERIZED TOMOGRAPHY
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DIAGNOSTIC USES
DIGESTIVE SYSTEM
DRUGS
EMISSION COMPUTED TOMOGRAPHY
GLANDS
HEART
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINE 131
IODINE ISOTOPES
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
KIDNEYS
LABELLED COMPOUNDS
LIVER
MUSCLES
MYOCARDIUM
NUCLEI
ODD-EVEN NUCLEI
ORGANS
POSITRON COMPUTED TOMOGRAPHY
RADIOISOTOPES
RADIOPHARMACEUTICALS
TECHNETIUM 99
TECHNETIUM ISOTOPES
TOMOGRAPHY
USES
YEARS LIVING RADIOI